CTI BioPharma Corp.
(NASDAQ : CTIC)

( )
CTIC After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corporation Plc Sponsored ADR
3.37%15.661.8%$144.53m
VRXValeant Pharmaceuticals International, Inc.
2.47%21.8314.1%$128.45m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-0.01%154.176.2%$82.55m
PRGOPerrigo Co. Plc
1.95%47.086.8%$73.13m
SAGESAGE Therapeutics, Inc.
1.45%164.358.6%$64.64m
JAZZJazz Pharmaceuticals Plc
0.68%135.752.3%$53.95m
HZNPHorizon Pharma plc
1.85%27.506.7%$44.87m
PTLAPortola Pharmaceuticals, Inc.
-1.51%29.957.5%$43.46m
UTHRUnited Therapeutics Corporation
0.55%81.8214.3%$42.45m
ICLRICON Plc
0.13%157.374.1%$38.97m
ICPTIntercept Pharmaceuticals, Inc.
3.45%66.2117.2%$37.20m
CTLTCatalent Inc
0.70%56.232.4%$36.67m
MDCOMedicines Company
1.44%33.1820.3%$34.12m
AERIAerie Pharmaceuticals, Inc.
2.98%23.886.8%$25.84m
PCRXPacira Pharmaceuticals, Inc.
-0.84%37.9010.5%$24.49m

Company Profile

CTI BioPharma Corp. operates as a biopharmaceutical company, which focuses on the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. Its products include PIXUVRI, Pacritinib, Tosedostat and Opaxio. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA.